Search Results - "Zhang, Rong M"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Clinical implications and guidelines for CKD in type 2 diabetes by Zhang, Rong M, Persson, Frederik, McGill, Janet B, Rossing, Peter

    Published in Nephrology, dialysis, transplantation (28-02-2023)
    “…Chronic kidney disease (CKD) is a complication of type 2 diabetes (T2D) with high morbidity and mortality. The prevalence of CKD in T2D is increasing due to…”
    Get full text
    Journal Article
  5. 5

    Immunity and Hypertension by Zhang, Rong M., McNerney, Kyle P., Riek, Amy E., Bernal‐Mizrachi, Carlos

    Published in Acta Physiologica (01-01-2021)
    “…Hypertension is the primary cause of cardiovascular mortality. Despite multiple existing treatments, only half of those with the disease achieve adequate…”
    Get full text
    Journal Article
  6. 6

    Retrospective Study on the Efficacy and Safety of Dulaglutide in Patients with Diabetes and Moderate-Advanced Chronic Kidney Disease by Kosaraju, Sriya, Zhang, Rong M

    “…Sriya Kosaraju,1 Rong M Zhang2 1Department of Biomedical Sciences, University of Missouri-Kansas City, Kansas City, MO, USA; 2Department of Medicine-Division…”
    Get full text
    Journal Article
  7. 7

    Update on Biosimilar Insulins: A US Perspective by Zhang, Rong M., Puri, Ritika, McGill, Janet B.

    “…The development of biosimilar insulin products has slowly evolved with only two follow-on biologics currently available to patients in the US. Both Basaglar ®…”
    Get full text
    Journal Article
  8. 8

    Tirzepatide Prescribing Practices and Efficacy in Patients with Diabetes and Chronic Kidney Disease at a Large Tertiary Care Center in the United States by Kosaraju, Sriya Amruta, Zhang, Rong M

    Published in Diabetes, metabolic syndrome and obesity (01-01-2024)
    “…Chronic kidney disease is a frequent complication of diabetes mellitus. Tirzepatide is the first dual glucose-dependent insulinotropic polypeptide and…”
    Get full text
    Journal Article
  9. 9

    Vitamin D 3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes by Riek, Amy E, Oh, Jisu, Darwech, Isra, Worthy, Veronica, Lin, Xiaobo, Ostlund, Jr, Richard E, Zhang, Rong M, Bernal-Mizrachi, Carlos

    “…Cross-sectional studies indicate consistent associations between low 25(OH)D concentration and increased risk of cardiovascular disease (CVD), but results of…”
    Get full text
    Journal Article
  10. 10

    The Nuances Surrounding Insulin Prescribing by McKee, Alexis M, Yancey, Abigail M, Zhang, Rong M, McGill, Janet B

    Published in Clinical diabetes (01-07-2023)
    “…Knowledge of and expertise in insulin prescribing is crucial for health care providers who care for people with diabetes. This article reviews the available…”
    Get full text
    Journal Article
  11. 11

    Deletion of JNK2 prevents vitamin-D-deficiency-induced hypertension and atherosclerosis in mice by Oh, Jisu, Riek, Amy E., Zhang, Rong M., Williams, Samantha A.S., Darwech, Isra, Bernal-Mizrachi, Carlos

    “…•JNK2 signaling links vitamin D deficiency to angiotensin-II-mediated hypertension.•JNK2 activation is necessary for vitamin D deficiency to induce…”
    Get full text
    Journal Article
  12. 12

    Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes by Riek, Amy E., Oh, Jisu, Darwech, Isra, Worthy, Veronica, Lin, Xiaobo, Ostlund, Richard E., Zhang, Rong M., Bernal-Mizrachi, Carlos

    “…•Vitamin D is first intervention to reduce monocyte cholesterol in type 2 diabetes.•Vitamin D replacement decreases monocyte CD36 expression and cholesterol…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors by Yang, Qiuxia, MD, Qi, Han, MD, Zhang, Rong, MD, Wan, Chao, MD, Song, Ze, MD, Zhang, Liang, MD, Fan, Weijun, MD

    “…Abstract Purpose To retrospectively evaluate risk factors related to incomplete computed tomography (CT)–guided radiofrequency (RF) ablation of metastatic and…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Pharmacokinetic Evaluation of [C]CEP-32496 in Nude Mice Bearing BRAF Mutation-Induced Melanomas by Cuiping Jiang MMSc, Lin Xie MD, PhD, Yiding Zhang BSc, Masayuki Fujinaga PhD, Wakana Mori MSc, Yusuke Kurihara PhD, Tomoteru Yamasaki PhD, Feng Wang MD, PhD, Ming-Rong Zhang MD, PhD

    Published in Molecular imaging (25-09-2018)
    “…CEP-32496, also known as RXDX-105 or Agerafenib, is a new orally active inhibitor for the mutated v-raf murine sarcoma viral oncogene homolog B1 (BRAF V600E ),…”
    Get full text
    Journal Article
  19. 19

    Impaired pancreatic β-cell compensatory function in Chinese patients with type 2 diabetes and high genetic risk: a 9-year prospective cohort study by Yan, Jing, BS, Peng, Danfeng, PhD, Jiang, Feng, PhD, Zhang, Rong, MS, Hu, Cheng, Prof, Jia, Weiping, Prof

    Published in The lancet. Diabetes & endocrinology (01-11-2016)
    “…Abstract Background Several prospective studies have shown that a genetic risk score combining multiple loci could predict incident type 2 diabetes in white…”
    Get full text
    Journal Article
  20. 20

    Overall and abdominal obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomisation study by Wang, Tao, BS, Ma, Xiaojing, PhD, Peng, Danfeng, PhD, Zhang, Rong, MS, Chen, Miao, PhD, Jiang, Feng, PhD, Bao, Yuqian, Prof, Hu, Cheng, Prof, Jia, Weiping, Prof

    Published in The lancet. Diabetes & endocrinology (01-11-2016)
    “…Abstract Background Clinical heterogeneity exists in overall obesity and central obesity in terms of susceptibility to type 2 diabetes, but the relationship is…”
    Get full text
    Journal Article